Cited by 3,357Gut microbiota and healthGastrointestinal motility and disordersProbiotics and Fermented Foods

The role of short-chain fatty acids in microbiota–gut–brain communication

Open access
Dalile, Boushra, Van Oudenhove, Lukas, Vervliet, Bram, Verbeke, Kristin·2019·Nature Reviews Gastroenterology & Hepatology

Abstract

Short-chain fatty acids (SCFAs), the main metabolites produced by bacterial fermentation of dietary fibre in the gastrointestinal tract, are speculated to have a key role in microbiota-gut-brain crosstalk. However, the pathways through which SCFAs might influence psychological functioning, including affective and cognitive processes and their neural basis, have not been fully elucidated. Furthermore, research directly exploring the role of SCFAs as potential mediators of the effects of microbiota-targeted interventions on affective and cognitive functioning is sparse, especially in humans. This Review summarizes existing knowledge on the potential of SCFAs to directly or indirectly mediate microbiota-gut-brain interactions. The effects of SCFAs on cellular systems and their interaction with gut-brain signalling pathways including immune, endocrine, neural and humoral routes are described. The effects of microbiota-targeted interventions such as prebiotics, probiotics and diet on psychological functioning and the putative mediating role of SCFA signalling will also be discussed, as well as the relationship between SCFAs and psychobiological processes. Finally, future directions to facilitate direct investigation of the effect of SCFAs on psychological functioning are outlined.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41575-019-0157-3

Cites

296 of 296 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The gut microbiota influences the gut barrier and produces neurotransmitters, amino acids and microbial metabolites.

    “The gut microbiota influences gut barrier and produce neurotransmitters, amino acids and microbial metabolites61.”

    From Association between attention-deficit/hyperactivity disorders and intestinal disorders: A systematic review and Meta-analysis (2025) · cites this paper as [61]

    The Introduction identifies short-chain fatty acids as microbial metabolites, and the Immune pathways section reports that they affect intestinal barrier function. The Other direct humoral pathways section says microbial metabolites can promote serotonin synthesis by host cells; it does not establish that the microbiota itself produces neurotransmitters or amino acids. Page numbers are unavailable in our copy. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Gut microbiota dysbiosis has been implicated in behavioral and neurologic pathologies, such as depression, Alzheimer's disease, Parkinson's disease, and autism spectrum disorder.

    “gut microbiota dysbiosis has been implicated in behavioral and neurologic pathologies, such as depression, Alzheimer's (AD) and Parkinson's (PD) diseases and autism spectrum disorder (ASD) (9, 21, 25–27).”

    From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]

    The Introduction (page unavailable) reports altered gut microbial composition in autism spectrum and mood disorders, supporting the autism and depression examples. Section 5 (page unavailable) reports fewer SCFA-producing bacteria in patients with Parkinson’s disease. Its Alzheimer’s discussion concerns effects of SCFAs in a mouse model and in vitro, not an association between gut microbiota dysbiosis and Alzheimer’s disease. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Brain-to-gut signaling can directly affect the microbiota via the immune system or gut functions such as motility, release of neurotransmitters, and intestinal immune tone.

    “brain to gut signaling can directly affect the microbiota, either via immune system or gut functions such as motility, release of neurotransmitters and intestinal immune tone (12, 17, 21, 31).”

    From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]

    The Introduction (page unavailable) says brain signals can alter gut sensorimotor and secretory functions and identifies the immune system as a possible route of microbiota–gut–brain communication. It does not establish that those brain-to-gut signals directly change the microbiota, nor does it specify neurotransmitter release or intestinal immune tone as routes for such a change. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • The gut microbiota can interact with the central nervous system via gut modulation or directly via metabolites and endotoxin translocation from the lumen to the circulation.

    “the gut microbiota can interact with the CNS via gut modulation or directly via metabolites and endotoxin translocation from the lumen to the circulation (9, 17, 21).”

    From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]

    The Introduction describes microbiota–gut–brain communication through gut-brain, nervous, endocrine and immune pathways. The Immune pathways section says short-chain fatty acids can reach the bloodstream and that intestinal barrier integrity can prevent translocation of bacteria and bacterial products into the circulation. It does not specifically establish endotoxin translocation as a direct route by which the microbiota interacts with the CNS; it describes a possible indirect route through systemic inflammation. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Altered short-chain fatty acid production has been demonstrated in a variety of neuropathologies.

    “altered SCFA production has been demonstrated in a variety of neuropathologies (19, 21, 33–35).”

    From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]

    Section 5 reports altered faecal SCFA concentrations in Parkinson’s disease, autism spectrum disorder and, in one study, depression, though findings for autism and depression conflict. Section 5.1 cautions that faecal concentrations do not reflect SCFA production rates, so the paper does not establish the claimed alteration in production. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [54]54. Mariadason, J. M., Barkla, D. H. & Gibson, P. R. Effect of short-chain fatty acids on paracellular permeability in Caco-2 intestinal epithelium model. American Journal of Physiology-Gastrointestinal and Liver Physiology 272, G705-G712 (1997).
  2. [57]57. Venkatraman, A., Ramakrishna, B. S., Pulimood, A. B., Patra, S. & Murthy, S. Increased permeability in dextran sulphate colitis in rats: time course of development and effect of butyrate. Scandinavian journal of gastroenterology 35, 1053-1059 (2000).

Cited by

Sorted by citations

Authors
Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K.
Affiliations
KU Leuven (BE)
Corresponding author
Verbeke, Kristin
Venue
Nature Reviews Gastroenterology & Hepatology
Published
2019-05-23
Volume
16
Issue
8
Pages
461-478
ISSN
  • 1759-5045 (ISSN-L)
  • 1759-5053
OpenAlex
W2946372752
Cited by
3,357
References
296
Citations by year
2026: 631 · 2025: 685 · 2024: 567 · 2023: 511 · 2022: 429 · 2021: 334 · 2020: 174 · 2019: 25 · 2014: 1
FWCI
21.30
Type
journal article
Language
en
Open access
Locations
  • Nature Reviews Gastroenterology & Hepatology (publishedVersion)
  • PubMed (publishedVersion)
  • Lirias (submittedVersion, other-oa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Keywords
short-chain fatty acids, microbiota-gut-brain axis, dietary fiber fermentation, gut microbiota, psychological functioning, emotional processing, cognitive processes, prebiotics, probiotics, microbiota-targeted interventions, immune signaling, hormone signaling, psychobiology
MeSH terms
Gastrointestinal Microbiome, Animals, Mental Disorders, Brain, Dietary Fiber, Disease Models, Animal, Fatty Acids, Volatile, Humans, Neural Pathways, Signal Transduction, Gastrointestinal Tract

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review